A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country

Authors :: Vianney Tricou
Susannah Eyre
Mahadev Ramjee
Paul Collini
Zenaida Mojares
Edde Loeliger
Sanja Mandaric
Martina Rauscher
Manja Brose
Inge Lefevre
Nicolas Folschweiller
Derek Wallace
Source :: Vaccine. 41:1398-1407
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Subjects :: Infectious Diseases
General Veterinary
General Immunology and Microbiology
Public Health, Environmental and Occupational Health
Molecular Medicine

Tools